FDA Warning Letter — Tulumba Marketing

Case 536006 — FEI 3011043426

The FDA took a Warning Letter action against Tulumba Marketing on Aug 18, 2017 (Jersey City, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Tulumba Marketing
Date
Aug 18, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Jersey City, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.